Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for EMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 949.00M
December 31, 2025 803.00M
September 30, 2025 933.00M
June 30, 2025 988.00M
March 31, 2025 894.00M
December 31, 2024 883.00M
September 30, 2024 980.00M
June 30, 2024 957.00M
March 31, 2024 926.00M
December 31, 2023 906.00M
September 30, 2023 880.00M
June 30, 2023 923.00M
March 31, 2023 1.051B
December 31, 2022 1.05B
September 30, 2022 1.137B
June 30, 2022 1.21B
March 31, 2022 1.187B
December 31, 2021 1.091B
September 30, 2021 1.356B
June 30, 2021 1.293B
March 31, 2021 1.229B
December 31, 2020 1.095B
September 30, 2020 1.077B
June 30, 2020 904.00M
March 31, 2020 1.045B
Date Value
December 31, 2019 1.045B
September 30, 2019 1.249B
June 30, 2019 1.295B
March 31, 2019 1.359B
December 31, 2018 1.216B
September 30, 2018 1.471B
June 30, 2018 1.449B
March 31, 2018 1.43B
December 31, 2017 1.026B
September 30, 2017 1.047B
June 30, 2017 1.018B
March 31, 2017 982.00M
December 31, 2016 812.00M
September 30, 2016 905.00M
June 30, 2016 951.00M
March 31, 2016 951.00M
December 31, 2015 792.00M
September 30, 2015 968.00M
June 30, 2015 1.021B
March 31, 2015 998.00M
December 31, 2014 936.00M
September 30, 2014 985.00M
June 30, 2014 1.071B
March 31, 2014 998.00M
December 31, 2013 880.00M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Dow, Inc. 5.185B
DuPont de Nemours, Inc. 1.699B
Albemarle Corp. 522.72M
Core Molding Technologies, Inc. 54.08M
Mativ Holdings, Inc. 200.20M